We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GTN:NYSEGray Media, Inc. Analysis

Data as of 2026-04-07 - not real-time

$4.74

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Gray Media, Inc. (GTN) is trading at $4.74, which sits just above the 20‑day SMA of $4.67 but below the 50‑day SMA of $4.74 and the 200‑day SMA of $4.98, indicating a short‑term pullback within a longer‑term downtrend. The technical suite shows a bearish MACD histogram, a neutral RSI at 51, and decreasing volume, all pointing to continued downside pressure toward the identified support level of $4.15. Valuation metrics reveal a forward P/E of 27.9, well above the industry average of 18, while the price‑to‑book (0.21) and price‑to‑sales (0.17) ratios are extremely low, suggesting the stock is cheap on a balance‑sheet basis but expensive on earnings expectations. Volatility is exceptionally high at 89% over the past 30 days, and the beta of roughly 1.3 signals amplified moves relative to the market, which aligns with the recent 2.9% price decline despite a broader market rally. The company pays a generous dividend yield of 7.1% with a payout ratio near 74%, yet it posted a negative profit margin of –2.7% and a trailing EPS of –$1.41, raising concerns about dividend sustainability. On the balance sheet, total debt of $5.8 B dwarfs cash of $368 M, yielding a debt‑to‑equity ratio of over 200, a red flag for financial stability.
Recent earnings commentary highlighted a Q4 revenue beat of $792 M against guidance and a $140 M capex plan for 2026 aimed at reducing leverage, indicating management’s focus on operational improvement. However, revenue growth remains negative at –24% year‑over‑year, and free cash flow, though positive, may be insufficient to offset the heavy debt load. The combination of high dividend yield, low valuation multiples, but weak earnings and substantial leverage paints a mixed picture: the stock may offer short‑term income appeal but carries significant downside risk if earnings do not improve.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators and decreasing volume
  • High dividend yield offering near‑term income
  • Proximity to support level limiting upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Management’s leverage‑reduction plan and capex spending
  • Continued earnings losses and high debt burden
  • Low price‑to‑book and price‑to‑sales suggesting upside if profitability recovers

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative earnings and high payout ratio
  • Elevated debt‑to‑equity ratio posing solvency concerns
  • Sector volatility and high beta amplifying downside risk

Key Metrics & Analysis

Financial Health

Revenue Growth-24.20%
Profit Margin-2.75%
P/E Ratio27.9
ROE-2.96%
ROA2.45%
Debt/Equity207.24
P/B Ratio0.2
Op. Cash Flow$289.0M
Free Cash Flow$279.6M
Industry P/E18.1

Technical Analysis

TrendBearish
RSI51.2
Support$4.15
Resistance$5.39
MA 20$4.67
MA 50$4.74
MA 200$4.98
MACDBearish
VolumeDecreasing
Fear & Greed Index77.52

Valuation

Target Price$7.30
Upside/Downside54.01%
GradeUndervalued
TypeValue
Dividend Yield7.13%

Risk Assessment

Beta1.32
Volatility89.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.